The carcinolytic effect of actinomycin C; a report of clinical studies.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D035843:Biomedical Research; D003609:Dactinomycin / Q000031:analogs & derivatives; D006689:Hodgkin Disease / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D009101:Multiple Myeloma; D009369:Neoplasms; D009447:Neuroblastoma
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; C030013:cactinomycin; D003609:Dactinomycin
ANTIBIOTICS/therapeutic use; HODGKIN'S DISEASE/therapy